18F-FDG胎儿剂量学:基于PET/MRI的计算
本研究回顾性分析11例妊娠期宫颈癌患者(12次扫描)的18F-FDG PET/MRI图像,通过MRI勾画胎儿感兴趣区推算胎儿吸收剂量。结果显示胎儿18F-FDG剂量很低,作者认为不应因妊娠而拒绝临床适当的18F-FDG扫描。
要点
- 11例妊娠早中期宫颈癌患者(12次扫描)行18F-FDG PET/MRI,回顾性计算胎儿吸收剂量。
- 胎儿估计剂量:妊娠早期1例为2.21E-02 mGy/MBq,近第一孕期末3例为7.38±0.25E-03 mGy/MBq,第二孕期8例为4.92±1.53E-03 mGy/MBq。
- 作者结论:胎儿18F-FDG剂量很低,不应因妊娠而拒绝临床适当的18F-FDG扫描。
核心结论
- 妊娠女性注射18F-FDG的PET/MR图像证实胎儿18F-FDG剂量非常低,因此不应因妊娠而拒绝癌症女性临床适当的18F-FDG扫描。
研究设计与样本
- 回顾性分析11例妊娠期宫颈癌女性(12次扫描)的18F-FDG PET/MRI图像,全部图像均以PET/MRI采集。
主要发现
- 由于MRI配准,早期妊娠后的所有胎儿均可被准确勾画。
- 18F-FDG活性在胎儿体内分布不均:心脏和膀胱一般可见,而脑部摄取较低。
- 胎儿估计剂量:妊娠早期1例为2.21E-02 mGy/MBq,近第一孕期末3例为7.38±0.25E-03 mGy/MBq,第二孕期8例为4.92±1.53E-03 mGy/MBq。
关键数值与推荐
- 胎儿注射活性分数由MRI层面手动勾画感兴趣区得出,胎儿时间积分系数由此推导并与ICRP第106号出版物中母亲器官标准系数结合。
- 胎儿吸收剂量用OLINDA/EXM 1.1和动态膀胱模型计算。
临床怎么用
- 作者结论认为,临床适当的18F-FDG扫描不应因妊娠而拒绝。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The fetal absorbed dose from 18F-FDG administration to the mother is an essential piece of information when considering the use of PET to stage cancers during pregnancy. However, the few existing human case reports were obtained using either PET-only or PET/CT machines, which may not accurately identify the soft tissues of the fetus for dosimetric calculations. This study presents data from 11 women injected with 18F-FDG for cancer staging during the first 2 trimesters of pregnancy and is, to our knowledge, the first to be entirely acquired with PET/MRI. Methods: Eleven pregnant women (12 scans) with cervical cancer were imaged with 18F-FDG PET/MRI, and their images were retrospectively analyzed for this study. The fraction of injected activity concentrated by the fetus was derived from manually drawing regions of interest on the MRI slices. From the activity fraction, the fetal time-integrated coefficients were derived and combined with the standard coefficients of the mothers' organs from the ICRP publication 106. The fetal absorbed doses were calculated with OLINDA/EXM 1.1 and a dynamic bladder model. Results: All fetuses after early pregnancy could be accurately delineated because of the coregistered MRI scans. 18F-FDG activity was unevenly distributed in the fetal body: the hearts and urinary bladders were generally visible, whereas the brain showed lower uptake. The estimated fetal doses were 2.21E-02 mGy/MBq for 1 woman imaged in early pregnancy, 7.38 ± 0.25 E-03 mGy/MBq for 3 women imaged at the end of the first trimester, and 4.92 ± 1.53 E-03 mGy/MBq for 8 women imaged during the second trimester. Conclusion: PET/MR images of pregnant women injected with 18F-FDG confirm that the fetal 18F-FDG dose is very low. Therefore, clinically appropriate 18F-FDG scans in women with cancer should not be withheld because of pregnancy.
引用
- Zanotti-Fregonara P, Ishiguro T, Yoshihara K, et al. 18F-FDG Fetal Dosimetry Calculated with PET/MRI. J Nucl Med. 2022. PMID: 35115366. doi:10.2967/jnumed.121.263561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。